跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SOMPRAZ IV POWDER FOR SOLUTION FOR INJECTION 40MG/VIAL - HSA Drug Approval Details
Approvals
/
HSA
/
SOMPRAZ IV POWDER FOR SOLUTION FOR INJECTION 40MG/VIAL
Approved
THERAPEUTIC
SOMPRAZ IV POWDER FOR SOLUTION FOR INJECTION 40MG/VIAL
SUN PHARMACEUTICAL INDUSTRIES LIMITED. (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Feb 27, 2019
Approval ID
30f5b125441bc407
Company
SUN PHARMACEUTICAL INDUSTRIES LIMITED. (INDIA)
Type
Therapeutic
Approval Details
Approval Id
30f5b125441bc407
Drug Name
SOMPRAZ IV POWDER FOR SOLUTION FOR INJECTION 40MG/VIAL
Product Name
SOMPRAZ IV POWDER FOR SOLUTION FOR INJECTION 40MG/VIAL
Approval Number
SIN15637P
Approval Date
2019-02-27
Registrant
RANBAXY (MALAYSIA) SDN. BHD.
Licence Holder
RANBAXY (MALAYSIA) SDN. BHD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
A02BC05
Atc Item Name
esomeprazole
Pharma Manufacturer Name
RANBAXY (MALAYSIA) SDN. BHD.
Company Detail Path
/organization/ranbaxy-malaysia-sdn-bhd
Active Ingredients
Esomeprazole Sodium 42.6 mg eq. to Esomeprazole
40.00mg
ESOMEPRAZOLE SODIUM 42.6 MG EQ. TO ESOMEPRAZOLE
40 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 27, 2019
Approval ID
30f5b125441bc407
Type
Therapeutic
Back to HSA Approvals
